Results 41 to 50 of about 97,768,533 (136)

Table_1_The Human Milk Oligosaccharide 2′-Fucosyllactose Alleviates Liver Steatosis, ER Stress and Insulin Resistance by Reducing Hepatic Diacylglycerols and Improved Gut Permeability in Obese Ldlr-/-.Leiden Mice.DOCX

, 2022
Non-alcoholic fatty liver disease (NAFLD) is a complex multifactorial disorder that is associated with gut dysbiosis, enhanced gut permeability, adiposity and insulin resistance. Prebiotics such as human milk oligosaccharide 2′-fucosyllactose are thought
Ivana Bobeldijk-Pastorova (254317), Martin Giera (1598620), Martien Caspers (568467), Frank Schuren (126104), Robert Kleemann (47402), Eveline Gart (10323017), Joline Attema (12889172), Christa de Ruiter (12889175), Yan Qin (118276), Marianne Heer (12889178), Kanita Salic (4225822), Martine C. Morrison (10323026)   +11 more
core   +1 more source

The Effect of Human Milk Oligosaccharides and Bifidobacterium longum subspecies infantis Bi-26 on Simulated Infant Gut Microbiome and Metabolites

Microorganisms, 2023
Human milk oligosaccharides (HMOs) shape the developing infant gut microbiota. In this study, a semi-continuous colon simulator was used to evaluate the effect of 2 HMOs—2′-fucosyllactose (2′-FL) and 3-fucosyllactose (3-FL)—on the composition of infant ...
Krista Salli, Johanna Hirvonen, Heli Anglenius, Ashley A. Hibberd, Ilmari Ahonen, Markku T. Saarinen, Johanna Maukonen, Arthur C. Ouwehand   +7 more
doaj   +1 more source

Short communication: Genotype-phenotype association analysis revealed different utilization ability of 2'-fucosyllactose in Bifidobacterium genus [PDF]

, 2021
peer-reviewedThe oligosaccharide 2'-fucosyllactose (2'FL) in human breast milk selectively promotes the proliferation of bifidobacteria. One hundred fifty-one Bifidobacterium strains were evaluated for their capacity to utilize 2'FL based on the ...
Liu, Xiaoming, Chen, Wei, Ross, R. Paul, Stanton, Catherine, Yang, Bo, Zhao, Jianxin, He, Zhujun, Zhang, Hao   +7 more
core   +1 more source

Bifidobacterium infantis and 2’-Fucosyllactose supplementation in early life may have potential long-term benefits on gut microbiota, intestinal development, and immune function in mice

, 2022
Bifidobacterium infantis and 2’-Fucosyllactose supplementation in early life may have potential long-term benefits on gut microbiota, intestinal development, and immune function in miceTHIS DATASET IS ARCHIVED AT DANS/EASY, BUT NOT ACCESSIBLE HERE.
罗, 雅 (via Mendeley Data), 罗, 雅亭   +1 more
core   +1 more source

Synthesis of fucosyllactose using α-L-fucosidases GH29 from infant gut microbial metagenome [PDF]

Fucosyl-oligosaccharides (FUS) provide many health benefits to breastfed infants, but they are almost completely absent from bovine milk, which is the basis of infant formula.
Moya Gonzálvez, Eva M., Zeuner, Birgitte, Holck, Jesper, Yebra, María J., Palomino Schätzlein, Martina, Thorhallsson, Albert Th., Thorhallsson, Albert, Meyer, Anne S., Yebra, María Jesús, Palomino-Schätzlein, Martina, Rodríguez-Díaz, Jesús, Moya-Gonzálvez, Eva M., PalominYebra Yebra, María Jeso-Schätzlein, Martina, Rodríguez Díaz, Jesús   +13 more
core   +2 more sources

Baseline data of mother-infant pairs in the Low- and High 2’Fucosyllactose groups.

, 2017
Baseline data of mother-infant pairs in the Low- and High 2’Fucosyllactose groups.
Norbert Sprenger (368719), Philippe Steenhout (3738235), Sagar K. Thakkar (2967768), Le Ye Lee (3738238), Carlos Antonio De Castro (3738241)   +4 more
core   +1 more source

Production and characterization of Aspergillus niger GH29 family α-fucosidase and production of a novel non-reducing 1-fucosyllactose

, 2020
Fucosylated oligosaccharides are interesting molecules due to their bioactive properties. In particular, their application as active ingredient in milk powders is attractive for dairy industries.
Ruvalcaba Medrano, Marcela, Salminen, Heidi, Tossavainen, Olli, Usvalampi, Anne, Maaheimo, Hannu, Frey, Alexander D.   +5 more
core   +1 more source

Research Progress in Metabolic Engineering Strategies for Microbial Synthesis of 2′-Fucosyllactose and 3-Fucosyllactose

Shipin gongye ke-ji
Human milk oligosaccharides (HMOs) are key components of breast milk, playing a vital role in fostering the healthy development of infants and young children.
Dengbin LI, Chao WEI, Yuan ZHANG, Genlin ZHANG, Xiaoyan WANG   +4 more
doaj   +1 more source

"Microbial and immune modulation by 2'-fucosyllactose supplementation during gestation: a strategy to prevent food allergies". [PDF]

Gut Microbes
International audienceFood allergies are linked to dysfunction in intestinal microbiota, the immune system and the intestinal epithelial barrier, leading to immune tolerance failure at birth.
Brosseau C, Rousseaux A, Le Romancer M, Ropers MH, Lollier V, De Carvalho M, Barbarot S, Bodinier M.   +7 more
europepmc   +2 more sources

Selective proliferation of intestinal Barnesiella under fucosyllactose supplementation in mice [PDF]

, 2017
The oligosaccharides 2-fucosyllactose and 3-fucosyllactose are major constituents of human breast milk but are not found in mouse milk. Milk oligosaccharides have a prebiotic action, thus affecting the colonisation of the infant intestine by microbiota ...
Hennet, Thierry, Chassard, Christophe, Weiss, Gisela A.   +2 more
core